Can p63 serve as a biomarker for diagnosing giant cell tumor of bone? A systematic review and meta-analysis

BACKGROUND: Tumor protein p63 (p63) has been reported to be highly expressed in giant cell tumor of bone (GCTB). Whether p63 can be treated as a diagnostic marker for GCTB remains unclear. OBJECTIVE: We conducted a meta-analysis to evaluate the applicability of p63 in diagnosing GCTB. DESIGN AND SET...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Zihao, Lee, Chien-Wei, Yuan, Shuai, Lee, Oscar Kuang-Shen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Paulista de Medicina - APM 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673867/
https://www.ncbi.nlm.nih.gov/pubmed/33111920
http://dx.doi.org/10.1590/1516-3180.2020.0021.R3.24062020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673867/
https://www.ncbi.nlm.nih.gov/pubmed/33111920
http://dx.doi.org/10.1590/1516-3180.2020.0021.R3.24062020

Ejemplares similares